Please use the arrows to navigate to the sub pages
Tissue Regenix Group
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products
Our vision is to establish Tissue Regenix Group as a leader in the science and innovation of regenerative medicine. We are committed to transforming patient care and delivering favourable health economic outcomes.
Signal Shares will be carrying out system maintenance from 6pm on 28 May until 6am on 31 May. If you are planning to cast your AGM votes through Signal Shares please ensure this is done in advance or between 6am on the 31 May and 12pm on the 1 June.
Regenerative medicine is an innovative and expanding field, researching the potential of tissue engineering to offer a natural recovery by triggering a response through the body’s own cells, and enable the natural regeneration of the patient’s own tissues.